.It is actually an uncommonly active Friday for biotech IPOs, along with Zenas BioPharma, MBX as wel...
.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 trial, yet the biote...
.Neurocrine Biosciences' schizophrenia system pivot has actually stopped working. The biotech was no...
.Sanofi has actually created an overdue entry to the radioligand gathering, paying for 100 thousand ...
.After F2G's very first attempt to receive a new course of antifungal to market was hindered due to ...
.Moderna has promised to reduce R&D spending by $1.1 billion by 2027. The decision to shrink the ...
.Only four months after Sanofi wager $80 thousand in ahead of time money on Pivot Therapies' losmapi...
.Cancer company Oncternal Therapies is folding all its own medical trials and also giving up workers...
.Roche is storing out chances that its own injectable being overweight possibility could at some poi...
.Novo Nordisk has elevated the cover on a phase 1 test of its own dental amylin and also GLP-1 recep...